![Dana Lee](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dana Lee
Corporate Officer/Principal bij
PHARMACYCLICS, INC.
Profiel
Dana Lee is currently Vice President-Drug Safety at Pharmacyclics LLC since 2013.
Formerly, Dr. Lee was Senior Director-Pharmacovigilance Division at Amylin Pharmaceuticals, Inc. in 2011 and Vice President-Medical Affairs at Mast Therapeutics, Inc. in 2012.
Dr. Lee earned a doctorate from The University of California, San Francisco.
Actieve functies van Dana Lee
| Bedrijven | Functie | Begin |
|---|---|---|
| PHARMACYCLICS, INC. | Corporate Officer/Principal | 01-02-2013 |
Eerdere bekende functies van Dana Lee
| Bedrijven | Functie | Einde |
|---|---|---|
Mast Therapeutics, Inc.
 Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapies for serious or life-threatening diseases with significant unmet needs | Hoofd Techniek/Wetenschap/O&O | 01-01-2012 |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Corporate Officer/Principal | 01-01-2011 |
Opleiding van Dana Lee
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
67
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Health Technology |
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis | Health Technology |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapies for serious or life-threatening diseases with significant unmet needs | Health Technology |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
